Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-Adjusted Indirect Comparison (MAIC)
Mark Rubinstein, David Rowe, Renee Perdok, Cindy Jacobs · 2026
Read Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-Adjusted Indirect Comparison (MAIC) by Mark Rubinstein, David Rowe, Renee Perdok, Cindy Jacobs (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13196912.txt.
Description
Mark Rubinstein, David Rowe, Renee Perdok, and Cindy Jacobs compare two quit-smoking drugs that have never met in a head-to-head trial, in a 2026 analysis. One is a plant-based drug newly tested in large trials, and the other is a standard first-choice aid. Both ease craving by acting on the same nicotine target in the brain.
The team reweighted trial data so the patient groups lined up, then compared quit rates and side effects. At three months the drugs looked even, but by six months the plant-based drug showed higher quit rates. It also caused far less nausea. The authors present it as a useful option for smokers who relapse or cannot stand the standard drug.
Catalog record
| CREATOR | Mark Rubinstein, David Rowe, Renee Perdok, Cindy Jacobs |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |